Medtronic Infuse Bone Graft Device Lawsuit
We are no longer accepting Medtronic medical device cases.
A California state court judge ruled in favor of a California resident represented by Baum Hedlund Aristei & Goldman, allowing her lawsuit against Medtronic to move forward. This is good news for patients across the country who received the Medtronic INFUSE® Bone Graft medical device procedure in an off-label manner, not approved by the FDA.
Lawyers Investigate Hospitals Where Spine Surgeries Caused Patients Severe Pain, Excessive Bone Growth and Other Complications
Baum Hedlund’s first Infuse case involves back surgery patient, April Cabana, who originally sued Medtronic, in addition to Stryker Biotech, her doctor, and Pomona Valley Hospital Medical Center, on July 13, 2011 after two different medical devices implanted during two different back surgeries resulted in debilitating and permanent injuries to her spine.
Baum Hedlund has Defeated Preemption In Ms. Cabana’s Case Three Times
- August 20, 2012 re Medtronic Infuse
- September 9, 2013 re Medtronic Infuse
- September 9, 2013 re Stryker OP-1 Putty
What is Medtronic INFUSE Bone Graft?
The FDA approved
Infuse Bone Graft Device in 2002 for a limited type of spinal fusion surgery to alleviate
severe back pain. Infuse Bone Graft Device is a liquid substance produced
by a genetically engineered Chinese hamster ovary cell line. It is a recombinant
bone morphogenetic protein (“BMP”) that is supposed to stimulate
controlled bone growth and fuse the vertebrae.
October 31, 2012
The U.S. Senate Finance Committee issued a lengthy report showing that medical device maker Medtronic, Inc. paid doctors hundreds of millions of dollars to manipulate studies and write favorable articles on the company’s popular bone graft product, InFUSE. Read More
Trouble for Medtronic INFUSE
Medtronic has been under scrutiny for years now concerning allegations
of illegal off-label promotion and use of Infuse Bone Graft Device, financial
conflicts of interest by researchers, under-reporting of complications
and overblown reports of superior clinical results. About 85% of Infuse
use is off-label according to MedPage Today.
- In July of 2011, the prominent medical journal, The Spine Journal, dedicated its entire journal to publishing numerous articles regarding the risks associated with the Infuse Bone Graft Device.
- Medtronic paid $85 million in March of 2012 to settle a shareholder lawsuit accusing it of making misleading statements concerning Infuse Bone Graft Device. According to a Reuters report, the settlement resolves claims that Medtronic failed to reveal that as much as 85.2 percent of Infuse sales depended on so-called “off-label” uses, where doctors sometimes paid by Medtronic would prescribe the product for applications not approved by the FDA.
- Although the U.S. Department of Justice closed its investigation into Medtronic’s marketing and alleged off-label use of Infuse Bone Graft in May of 2012, Senators Charles Grassley (R-Iowa) and Max Baucus (D-Mont.) have investigations pending looking into allegations that Medtronic failed to report Infuse Bone Graft side effects and that the company may have had financial ties to clinical investigators.
- Last summer Medtronic commissioned researchers at Yale University with a $2.5M grant to conduct an independent review of the safety and effectiveness of Infuse Bone Graft, including all patient data generated during the Infuse clinical trials. Although Yale stated it would make the results of its review public by summer of 2012, it has yet to do so.
Contact us by filling out the online form.
-
Pilliod et al. v. Monsanto Co. $2 Billion
-
Dewayne “Lee” Johnson v. Monsanto Co. $289.2 Million
-
Pharmaceutical Settlement $105 Million
-
Hardeman v. Monsanto Co. $80 Million
-
Paxil Pediatric Class Action $63 Million
-
Third-Party Payer Class Action $40 Million
-
Defective Drug Class Action $28 Million
-
Whistleblower Settlement $18 Million
$18 million settlement for Boeing government overcharging on aircraft maintenance
-
A Major US Plane Crash $17.5 Million
-
Commercial Truck Accident $15 Million
$15 million settlement for a person gravely injured by a major truck company


-
The U.S. News – Best Lawyers® “Best Law Firms” rankings are based on lawyer evaluations, peer review from leading attorneys in their field, and review of additional information provided by law firms as part of the formal submission process.
-
The National Trial Lawyers Top 100 recognized the law firms of Baum Hedlund Aristei & Goldman, the Miller Firm and Audet & Partners with the 2019 Trial Team of the Year award (in the Mass Torts category) for their work in the groundbreaking case of Dewayne “Lee” Johnson v. Monsanto Company.
-
NLJ and American Lawyer Media honor law firms and attorneys as Elite Trial Lawyers for their cutting-edge legal work on behalf of plaintiffs in practice areas ranging from mass torts to securities litigation.
-
Less than one-half of one percent of firms across the nation have achieved this ranking. A firm must have a high percentage of lawyers who have achieved the prestigious AV® Preeminent rating by Martindale-Hubbell®.
-
Best Lawyers is the oldest and most respected peer-review publication in the legal profession. A listing in Best Lawyers is widely regarded by both clients and legal professionals as a significant honor, conferred on a lawyer by his or her peers.
-
The National Law Journal inducted Baum Hedlund into the Verdicts Hall of Fame for obtaining the $2 billion landmark verdict in the Roundup cancer case of Pilliod et al. v. Monsanto. The verdict was #1 in California and #2 in the U.S. in 2019 and is #9 in American history.
-
An AV® rating reflects an attorney who has reached the heights of professional excellence. The rating signifies the highest legal ability, and very high adherence to professional standards of conduct, ethics, reliability, and diligence.
-
Super Lawyers is a rating service of outstanding lawyers from more than 70 practice areas who have attained a high-degree of peer recognition and professional achievement.
-
The National Board of Trial Advocacy is dedicated to bettering the quality of trial advocacy in our nation’s courtrooms and helping consumers find experienced and highly qualified trial lawyers.
-
The NADC is an organization dedicated to promoting the highest standards of legal excellence. Only the elite few attorneys are invited to join the NADC, less than 1% of practicing attorneys in the U.S.
-
Multi-Million Dollar Advocates Forum is one of the most prestigious groups of trial lawyers in the United States. Membership is limited to attorneys who have won million and multi-million-dollar verdicts and settlements.
-
The Bar Register is the definitive guide to the most distinguished law firms in America. It includes only those select law practices that have earned the highest rating in the Martindale-Hubbell Law Directory and have been designated by their colleagues as preeminent in their field.

Firm Reviews
What Our Clients Are Saying
-
Top Legal Minds in the Country
“The Baum, Hedlund firm has some of the top legal minds in the country; they are driven, determined, trustworthy, ethical and passionate.”
- From Best Lawyers® Best Law Firms -
I Can’t Imagine a Better Law Firm
“Multiple lawyers recommended Baum Hedlund to me and I have been consistently impressed with the quality of their work.”
- Best Law Firms Survey -
Diligent & Professional Representation
“Thanks to your efforts I was able to recover from a tragic experience and turn my life around for the best.”
- W.T. -
Our Best Interest Was Always Number One on Your List
“A special thank you to your Spanish-speaking staff for the extra effort put into this case. The language barrier was never a problem, and we are so very thankful to them. Your name holds much respect in our family.”
- G.C. & C.C -
We Have Never Met a More Wonderful Group of People
“It is obvious that the people at Baum, Hedlund, Aristei, & Goldman believe in what they do. And that you all really care about your clients.”
- The B. Family